Bajaj Healthcare Limited (BHL), a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and finished formulations, has announced the re-appointment of Mr. Anil Champalal Jain as its Managing Director. His new term is set to commence on April 1, 2026. Mr. Jain has been a pivotal figure in the company’s growth, steering its expansion into specialized chemical segments and strengthening its manufacturing infrastructure. This re-appointment ensures continuity in leadership as the company targets higher growth in domestic and international pharmaceutical markets.
Trending
- Pernod Ricard India Appoints Sonia Arora as Director of Consumer Insights
- PM Narendra Modi Becomes India’s Longest-Serving Head of Government
- Whole-time Director Indirakumar Resigns from Indrayani Biotech Board
- Secretary Debashree Mukherjee Assigned Additional Charge as Chairperson, NCVET
- Chief Growth Officer Amber Faulkner Joins Droga5 London
- Minister Laljit Singh Bhullar Resigns from Punjab Cabinet Following Official’s Suicide
- Sagarsoft (India) Appoints Finance Veteran Kanakadhara Srinivasan to its Board
- IAS Pramod Kumar Meherda Assigned Additional Charge as CEO, NRAA
